[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.128.52. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Review
July 2006

Pathomechanisms of Harlequin Ichthyosis and ABCA Transporters in Human Diseases

Author Affiliations

Author Affiliation: Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

Arch Dermatol. 2006;142(7):914-918. doi:10.1001/archderm.142.7.914
Abstract

Objectives  To review recent advances in our understanding of the genetic pathomechanisms of harlequin ichthyosis (HI) (the most devastating subtype of congenital ichthyoses) and its prenatal diagnosis and to discuss the possibility of future gene therapy.

Data Source  PubMed search for articles about HI, its causative protein adenosine triphosphate–binding cassette A12 (ABCA12), and related molecules.

Study Selection  English-language studies were selected if they provided useful information about the pathomechanisms of HI and ABCA lipid transporters.

Data Synthesis  This article describes ABCA12 as a causative molecule involved in defects in HI, summarizes the known genetic disorders caused by genetic defects in ABCA lipid transporters, and highlights the prospects of prenatal diagnosis and gene therapy for HI.

Conclusions  Harlequin ichthyosis is caused by a serious functional deficiency of ABCA12. ABCA12 and ABCA3 are essential lipid transporters for human adaptation to a dry terrestrial environment. In clinical practice, information regarding the genetic defects and pathomechanisms underlying HI is important for precise diagnosis, genetic counseling, and prenatal diagnosis.

×